BIOL 520 Advanced Immunology W2009 Lecture 1 Overview Immunology Lecture 1 Overview Immunology.
Immunology Summit UCB
-
Upload
juan-g-ovalles-b -
Category
Documents
-
view
13 -
download
1
description
Transcript of Immunology Summit UCB
-
SIXTH INTERNATIONAL IMMUNOLOGY SUMMITOptimizing management of musculoskeletal diseases:
treating the human and the being
Chair: Peter Taylor
Prague, 1214 March 2015
First announcement
This educational event is organized by UCB
All attendees will have the opportunity to participate in a number of mini-symposia. All workshops will be facilitated by expert faculty. Further information about these sessions and how to register for your preferred option will be available on our upcoming website.
Topics will include Patient communication workshop: how can your patient help you treat their
disease better?
Pain and the brain: how neuroscience neurobiology helps us deal better with rheumatic disease
Therapeutic drug monitoring strategies
Managing co-morbidities in rheumatic diseases: the impact of peripheral inflammation on body and mind
Detecting depression and anxiety disorders in rheumatic diseases: practical tips, everyday solutions
Interpreting MRI in AxSpA
Challenging cases in AxSpA: right patient, right treatment
Diagnosis and monitoring of AxSpA in the clinic
Beyond evidence-based medicine: what have we learned about biologic therapies in observational studies?
Difficult cases in rheumatology: RA and PsA
Use of musculoskeletal ultrasound in rheumatic disease: RA and PsA
Diagnosis and management of PsA: a shared responsibility between disciplines
How do we manage pregnancy in women suffering from RA/AxSpA/PsA?
Clinical care of vasculitis
Programme may be subject to change
Planned mini-symposia sessions
IMNL-EDU-001004
Right page (Folds in under front page)146 mm
Back page!48 mm
Front page148 mm
210mm
CIM14711214
U047868Text BoxCIM0870115CER0940115
-
Throughout the Summit, there will be opportunities to participate in a number of mini-symposia.
Summit Open
Session chairPeter TaylorFacultyMaxime Dougados Karel Pavelka Jiri Vencovsky
Welcome reception and Summit introduction
Beyond treat-to-target: a holistic approach to treatment of rheumatic diseases
Session chairPeter TaylorFacultyRakesh Jain Laure Gossec
Putting patients at the heart of care: changing needs in the face of evolving therapies
Treating the mind and the body: an integrated approach to chronic pain
Patient-reported outcomes: their views can help us improve their wellbeing
Improving the patient experience in SLE
Session chairThomas DrnerFacultyIan Bruce Susan Manzi
B cell biology in the SLE disease course: why this matters
Practical guidance on treatment goals in SLE
Best practice for management of co-morbidities
Management of disorders of bone in immunoinflammatory disease: do we need to do more?Session chair Socrates PapapoulosFacultyEugene McCloskey Lorenz Hofbauer
New insights on the pathophysiology of inflammation-induced bone disease
Effects of current therapeutics on BMD and fracture risk
Beyond inhibition of excess bone remodelling
Clinical care of vasculitisSession chair Ian BruceFacultyDavid DCruz Stephen Hall
State-of-the-art in vasculitis management
Optimizing pharmacology in RA: what are the patient outcomes beyond symptom control?Session chair Maxime DougadosFacultyMichael Schiff Gerd Burmester Christopher D Buckley
Global perspectives: management of early RA optimized MTX and early use of biologic therapy to improve long-term outcomes
Towards early arthritis management: a TEAM approach
It is with great pleasure that I warmly invite you to the Sixth International Immunology Summit on Optimizing management of musculoskeletal diseases: treating the human and the being.
We have witnessed extraordinary advances in the understanding of musculoskeletal diseases over the past decade and a half, as well as an increase in pharmacotherapeutic options. However, despite the greatly improved outlook for patients with certain conditions, such as rheumatoid arthritis and axial spondyloarthritis, very significant unmet needs remain. While severe disability has fortunately become less common, and more patients remain in employment, they may still face difficulties that may not be immediately apparent to their physicians, e.g. pain and fatigue. We
must now look at the total burden of chronic disease in our patients lives and how best we can optimize every aspect of their quality of life.
Much of the therapeutic advance of recent years has focused on improving immune dysregulation in the assumption that emotional, mental and global health will improve correspondingly. Indeed, while this is sometimes the case, there is often discordance between improvements in objective measures of disease activity and the patients own assessment of their wellbeing. It might be said that optimizing pharmacotherapeutic intervention has focused on the pathophysiological aspects of human disease. In English we refer to our species as human beings, so there is another dimension to us the being beyond the physiological alone, which determines how we perceive and experience the world. Of course, these two aspects, the human and the being are interdependent our feelings affect our health and our health affects our perceptions and emotions.
The objective of the Summit is to discuss, share and learn how we can adopt a more holistic approach to caring for our patients beyond simply modifying disease activity, that is, how can we aspire to optimize patient wellbeing? We have an exciting programme and are fortunate in having a prestigious faculty to inspire and help us on our journey. Discussions will encompass the spectrum of rheumatic disease PsA, AxSpA, RA and SLE as well as disorders of bone and the challenges of family planning and pregnancy in autoimmune conditions. New this year is a state-of-the-art plenary session on vasculitis. In addition to the plenaries, mini-symposia sessions will explore and expand on the plenary topics and give attendees the opportunity to meet with faculty and one another in smaller groups.
Our intention is to foster an atmosphere of sharing and participation through the use of interactive formats including debates, panel discussions, case studies and hands-on workshops. We will also harness the latest in multimedia technology to enhance learning.
I look forward to welcoming you to Prague.
Professor Peter TaylorUniversity of Oxford, UK
Evolution to revolution: progress in the understanding and management of AxSpA
Session chairDsire van der HeijdeFacultyMartin Rudwaleit Filip van den Bosch Robert Landew Dominique Baeten
The importance of early, accurate diagnosis in AxSpA
Practical guidance on managing extra-articular features to improve patients daily lives
Disease modification in AxSpA
Current management, and emerging pathways, treatment targets and strategies
Virtual clinic: interactive case
How can we optimize management in PsA to further enhance patients lives?
Session chairIain McInnesFacultyPeter Nash Wolf-Henning Boehncke
Living with the dual burden of PsA: the patient viewpoint
Practical guidance on managing comorbidities in PsA wellbeing as a therapeutic target
The future of PsA management emerging strategies and therapies
Challenges in planning and managing pregnancy in autoimmune diseaseSession chairDimitrios BoumpasFacultyCatherine Nelson-Piercy
The patient-physician journey: what can we do for better outcomes? Viewpoints from the patient, the obstetric physician and the rheumatologist
Day and Summit Close
Session chairPeter Taylor
Programme may be subject to change
ProgrammeDear Colleagues and Friends
Inside left page 148 mm
Inside middle!48 mm
Inside right page (Folds in under left page) 146 mm
210mm
CIM14711214